CAS: 39910-98-0; 4'-Morpholinoacetophenone

该化合物是有机化合物,其特点是附于丙酮结构的甲状腺素组.该化合物一般是白色至白色晶体固体,以其在聚合化学中作为光化剂的作用而著称,特别是在紫外线光线照射时促进聚合作用的紫外线照射启动;甲状醇组的存在,增强了其在各种有机溶剂中的溶性,使其适合在涂层,粘合剂和墨水中的多种应用.此外,4欧元-摩利诺酚酮在环境条件下具有中等稳定性,但因特定情况下潜在的再活动而应加以谨慎处理.其化学特性包括相对较低的熔点和有机溶剂中具体的溶性范围,这可以因溶剂的极度而不同.与许多有机化合物一样,在处置该物质时,在使用适当的个人防护设备时,应注意安全防范措施,包括使用适当的个人防护设备.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

4-(4-溴苯基)吗啉 4-Bromophenyl-Morpholine 30483-75-1
4-氨基苯乙酮 4-Aminoacetophenone 99-92-3

合成工艺路线路线简述

    4-碘代苯乙酮置于potassium Fluoride,对甲苯磺酸一水合物,间氯过氧苯甲酸体系中,用 水,1,2-二氯乙烷,乙腈 作为反应溶剂,化学反应 25.25H,反应生成 4-(4-吗啉基)苯乙酮
    参考文献:芳胺的无金属合成:超越亲核芳香取代
    标题:芳胺的无金属合成:超越亲核芳香取代
    摘要:描述了一种温和且无金属的c-N偶联方法,该方法使用二芳基碘鎓盐亲电试剂和脂肪族仲胺亲核试剂.该反应导致碘鎓部分直接ipso取代,主要使用不对称的芳基(tmp)碘鎓盐.此外,可以容纳目前对经典的无金属方法构成挑战的芳烃取代基和取代形式,并且此处使用的脂环族胺亲核试剂在其他当代的无金属cn偶联反应中是前所未有的.
    DOI:10.1002/anie.201610086

    海关参考信息

    专利信息


    专利号:US-6413957-B1
    优先权日:1998-04-21
    标题:Methods of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
    权利人:BRISTOL MYERS SUIBB PHARMA COM
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): n that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G. This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

    专利号:US-6689882-B2
    优先权日:2000-05-18
    标 题 :Process for the synthesis of morpholinylbenzenes
    发明人:TIAN WEI
    权利人:ASTRAZENECA AB
    摘要:A new improved process for synthesizing morpholinylbenzenes of the formula I by reacting morpholine of formula II with a substituted benzene of formula III, wherein morpholine is used as a reactant and as the only one solvent.

    专利号:US-7250435-B2
    优先权日:1999-10-20
    标 题:Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; VIDWANS ANUP P; YUE EDDY
    权利人:BRISTOL MYERS SQUIBB PHARMA CO
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): n nthat are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G.n n This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

    专利号:US-2003171581-A1
    优先权日:2000-05-18
    标题:Process for the synthesis of morpholinylbenzenes

    专利号:US-6407103-B2
    优先权日:1998-04-21
    标 题:Indeno [1,2-c] pyrazol-4-ones and their uses
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
    权利人:BRISTOL MYERS SQUIBB PHARMA CO
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I):that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-9 and their regulatory subunits know as cyclins A-H.This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

    专利号:US-2008045708-A1
    优先权日:2000-05-18
    标 题 :New Process for the Synthesis of Morpholinylbenzenes
    天津安浩生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ahpharmatech.com
    企业联系电话:022-84840027👤
    📞天津安浩生物科技有限公司 ⚠️参考联系方式
    联系人:马经理
    电话:022-84840027

    传真:022-84840027
    邮箱:sales@ahpharmatech.com
    通信地址: 天津市东丽区四纬路10号2-201
    邮编: 300300
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市东丽区四纬路10号2-201
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Singh, F. V., Science of Synthesis Knowledge Updates, (2021) 1, 168.
    摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 142.
    摘要:Xiong, T.; Li, Y., Science of Synthesis: Special Topics, (2022) 1, 44.
    摘要:Kiyokawa, K., Science of Synthesis: Hypervalent Halogens in Organic Synthesis, (2025) .
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知